Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea

Haemophilia. 2023 Jul;29(4):1163-1166. doi: 10.1111/hae.14819. Epub 2023 Jun 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Hemophilia A* / drug therapy
  • Humans
  • Republic of Korea / epidemiology

Substances

  • Antibodies, Bispecific
  • emicizumab